Patents by Inventor Robert Jaap

Robert Jaap has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210227670
    Abstract: A lighting control system configured to cooperate with a light source for illuminating an object in a space to recreate an ambiance, the lighting control system arranged to input a setting related to a scene intended for the space to the light source via a user interface; wherein the lighting control system further comprises a configuration module arranged in signal communication with the user interface for: a) providing at least one preset scene from a plurality of preset scenes according to: i) a preset type of space in which the light source is positioned from a plurality of preset types of spaces; and ii) a preset type of object that said light source is intended to illuminate from a plurality of preset types of objects; and b) inputting the setting to the light source according to the at least one preset scene of the plurality of preset scenes.
    Type: Application
    Filed: April 25, 2017
    Publication date: July 22, 2021
    Inventors: Robert Jaap Timmer, Jeroen Elles Wilhelmus Martinus Dalderop, Gerry Vermeulen
  • Patent number: 7838518
    Abstract: The present invention relates to 1-arylsulfonyl-3 substituted indole or indoline derivatives having the general formula (I) (I) wherein the dotted line represents an optional bond; n is 0 or 1; m is 0-5 and Ar, R6-R11 are defined in the description. The invention further relates to pharmaceutical compositions comprising said derivatives, and to the use of these 1-arylsulfonyl-3-substituted indole or indoline derivatives in the treatment of central nervous disorders such as psychosis, schizophrenia, manic depressions, depressions, neurological disorders, cognitive enhancement, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease and Huntington's disease.
    Type: Grant
    Filed: February 5, 2003
    Date of Patent: November 23, 2010
    Assignee: N.V. Organon
    Inventors: Daniel Spinks, Richard E. Armer, David J. Miller, Zoran Rankovic, Gayle Spinks, Jordi Mestres, David Robert Jaap
  • Publication number: 20070198748
    Abstract: A power line communication (PLC) hub incorporates multiple network communication media and services for devices. Implementations can be plugged into an electrical outlet to furnish a single point for both electrical power and network connectivity. Each of the electrical outlets is tied through an electrical distribution system to a network through a conventional PLC bridge to provide network connectivity through the electrical distribution system using PLC technology. The PLC outlet hub can include various combinations of applications and/or services including Voice Over Internet Protocol (“VoIP”) gateway, media server, Internet router/gateway, Local Area Network (“LAN”), both wired and wireless voice and video conferencing capability, including a VoIP, Voice over WiFi (“VoWiFi”), Power Over Ethernet (“PoE”), Wireless 802.11a/b/g/n capability and (Wireless Universal Serial Bus “WUSB”/Ultra Wide Band “UWB”) wireless connectivity, and Blue Tooth. Versions of the PLC outlet hub can have an Ethernet IEEE 802.
    Type: Application
    Filed: February 1, 2007
    Publication date: August 23, 2007
    Applicant: LEVITON MANUFACTURING CO., INC.
    Inventors: Julius Ametsitsi, Robert Jaap, Frank Kim, Nelson Taylor, Ross Goldman
  • Publication number: 20030149269
    Abstract: The present invention relates to certain novel substituted piperidine derivatives, to processes for their preparation, to pharmaceutical formulations containing them and to their use in medical therapy, particularly in the treatment of psychotic disorders.
    Type: Application
    Filed: January 28, 2003
    Publication date: August 7, 2003
    Inventors: Duncan Robertson Rae, David Robert Jaap
  • Publication number: 20020165395
    Abstract: The present invention relates to certain novel substituted piperidine derivatives, to processes for their preparation, to pharmaceutical formulations containing them and to their use in medical therapy, particularly in the treatment of psychotic disorders.
    Type: Application
    Filed: April 25, 2002
    Publication date: November 7, 2002
    Inventors: Duncan Robertson Rae, David Robert Jaap
  • Publication number: 20020087001
    Abstract: The present invention relates to certain novel substituted piperidine derivatives, to processes for their preparation, to pharmaceutical formulations containing them and to their use in medical therapy, particularly in the treatment of psychotic disorders.
    Type: Application
    Filed: January 11, 2002
    Publication date: July 4, 2002
    Inventors: Duncan Robertson Rae, David Robert Jaap
  • Patent number: 6365604
    Abstract: The present invention relates to certain novel substituted piperidine derivatives of formula (I) to processes for their preparation, to pharmaceutical formulations containing them and to their use in medical therapy, particularly in the treatment of psychotic disorders.
    Type: Grant
    Filed: June 1, 2000
    Date of Patent: April 2, 2002
    Assignee: Akzo Nobel NV
    Inventors: Duncan Robertson Rae, David Robert Jaap
  • Patent number: 5935974
    Abstract: The invention relates to a diphenylmethylene piperidine derivative of the formula ##STR1## wherein n is 1 or 2; or a pharmaceutically acceptable salt thereof, for use in therapy, in particular for use as a dopamine antagonist for the treatment or prophylaxis of psychotic disorders.
    Type: Grant
    Filed: January 7, 1998
    Date of Patent: August 10, 1999
    Assignee: Akzo Nobel, N.V.
    Inventors: Duncan Robertson Rae, David Robert Jaap